slotkoers
Korea S.E.
00:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
1.637
KRW
|
+0,12%
|
|
-1,15%
|
-21,67%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
51.977
|
56.995
|
114.036
|
80.970
|
38.678
|
27.081
|
Bedrijfswaarde
1 |
43.184
|
49.830
|
123.462
|
113.122
|
74.363
|
73.651
|
K/w-verhouding
|
-27,6
x
|
189
x
|
-10
x
|
-39,1
x
|
-20,5
x
|
-5,29
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
2,19
x
|
1,77
x
|
3,05
x
|
2,59
x
|
0,82
x
|
0,7
x
|
Bedrijfswaarde/omzet
|
1,82
x
|
1,54
x
|
3,31
x
|
3,62
x
|
1,58
x
|
1,91
x
|
Bedrijfswaarde/EBITDA
|
-16,3
x
|
24,7
x
|
-32,3
x
|
-97,5
x
|
43,1
x
|
247
x
|
Bedrijfswaarde/FCF
|
-5,94
x
|
8,53
x
|
-4,66
x
|
-4,58
x
|
-13,8
x
|
-8,19
x
|
FCF Yield
|
-16,8%
|
11,7%
|
-21,5%
|
-21,8%
|
-7,22%
|
-12,2%
|
Price to Book
|
2,45
x
|
2,11
x
|
4,01
x
|
2,54
x
|
1,29
x
|
1,22
x
|
Aantal aandelen (in duizenden)
|
10.044
|
10.614
|
12.093
|
12.873
|
12.958
|
12.958
|
Referentieprijs
2 |
5.175
|
5.370
|
9.430
|
6.290
|
2.985
|
2.090
|
Datum van publicatie
|
01-03-19
|
29-02-20
|
01-03-21
|
01-03-22
|
01-03-23
|
29-02-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
23.758
|
32.290
|
37.344
|
31.238
|
46.918
|
38.616
|
EBITDA
1 |
-2.655
|
2.017
|
-3.819
|
-1.160
|
1.726
|
298,2
|
Bedrijfsresultaat (EBIT)
1 |
-3.465
|
642,3
|
-5.404
|
-3.861
|
-2.521
|
-4.025
|
Operationele Marge
|
-14,58%
|
1,99%
|
-14,47%
|
-12,36%
|
-5,37%
|
-10,42%
|
Resultaat voor belastingen (EBT)
1 |
-4.074
|
14,38
|
-10.568
|
-1.926
|
-1.866
|
-5.054
|
Nettowinst (verlies)
1 |
-4.617
|
279,6
|
-10.879
|
-1.926
|
-1.880
|
-5.054
|
Nettomarge
|
-19,43%
|
0,87%
|
-29,13%
|
-6,16%
|
-4,01%
|
-13,09%
|
WPA
2 |
-187,4
|
28,42
|
-939,9
|
-160,9
|
-145,5
|
-395,0
|
Free Cash Flow
1 |
-7.268
|
5.844
|
-26.499
|
-24.716
|
-5.372
|
-8.994
|
FCF-marge
|
-30,59%
|
18,1%
|
-70,96%
|
-79,12%
|
-11,45%
|
-23,29%
|
Kasstroomconversie (ebitda)
|
-
|
289,71%
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
2.090,15%
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
01-03-19
|
29-02-20
|
01-03-21
|
01-03-22
|
01-03-23
|
29-02-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
9.426
|
32.152
|
35.685
|
46.570
|
Nettokaspositie
1 |
8.793
|
7.164
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-2,468
x
|
-27,71
x
|
20,68
x
|
156,2
x
|
Free Cash Flow
1 |
-7.268
|
5.844
|
-26.499
|
-24.716
|
-5.372
|
-8.994
|
ROE (netto-inkomsten/eigen vermogen)
|
-23,8%
|
1,18%
|
-35,4%
|
-5,91%
|
-6,1%
|
-19,6%
|
ROA (netto-inkomsten/totale activa)
|
-5,68%
|
0,78%
|
-5,3%
|
-2,84%
|
-1,62%
|
-2,6%
|
Totale activa
1 |
81.225
|
35.666
|
205.237
|
67.811
|
116.413
|
194.203
|
Nettoactief per aandeel
2 |
2.113
|
2.550
|
2.349
|
2.475
|
2.322
|
1.719
|
Cashflow per aandeel
2 |
1.144
|
450,0
|
344,0
|
35,80
|
279,0
|
424,0
|
Capex
1 |
4.673
|
2.161
|
15.765
|
36.684
|
11.422
|
843
|
Capex/omzet
|
19,67%
|
6,69%
|
42,22%
|
117,43%
|
24,34%
|
2,18%
|
Datum van publicatie
|
01-03-19
|
29-02-20
|
01-03-21
|
01-03-22
|
01-03-23
|
29-02-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -21,67% | 16,22 mln. | | +1,51% | 42,75 mld. | | +49,22% | 41,61 mld. | | +8,57% | 41,34 mld. | | -12,36% | 26,59 mld. | | +8,92% | 25,49 mld. | | -25,13% | 18,12 mld. | | +29,17% | 12,24 mld. | | -3,12% | 11,76 mld. | | +6,35% | 11 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|